Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Abcellera Biologics Inc (ABCL)

Abcellera Biologics Inc (ABCL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
AbCellera Announces Changes to Its Board of Directors

AbCellera (Nasdaq: ABCL), a technology company with a centralized operating system for next-generation antibody discovery, today announced changes to its Board of Directors with the appointment of Andrew...

ABCL : 7.81 (-6.69%)
Pre-Market Brief: Stocks Set to Open Higher as Omicron Concerns Ease

Morning Markets Dec S&P 500 futures this morning are up by +0.31%. Stock indexes are climbing this morning as the most recent data from South Africa shows that the omicron Covid variant is not as severe...

FDS : 406.86 (-1.84%)
SEDG : 214.13 (+0.65%)
SBNY : 305.54 (-1.54%)
DVN : 51.79 (+1.03%)
MRO : 19.61 (+0.56%)
OXY : 37.06 (+0.79%)
SLB : 39.80 (+2.60%)
EW : 108.63 (-0.79%)
ABCL : 7.81 (-6.69%)
ET : 9.69 (+4.31%)
RIOT : 14.33 (-2.12%)
MARA : 21.46 (-3.25%)
AbCellera-Discovered Bamlanivimab Together with Etesevimab Authorized as the First and Only Antibody Therapy for Emergency Use in COVID-19 Patients Under the Age of 12

AbCellera (Nasdaq: ABCL) today announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab and etesevimab administered together to include...

ABCL : 7.81 (-6.69%)
AbCellera Announces the Appointment of Neil Aubuchon as Chief Commercial Officer

AbCellera (Nasdaq: ABCL), a technology company with a centralized operating system for next-generation antibody discovery, announced today the appointment of Neil Aubuchon as Chief Commercial Officer...

ABCL : 7.81 (-6.69%)
AbCellera Reports Q3 2021 Business Results

AbCellera (Nasdaq: ABCL), a technology company with a centralized operating system for next-generation antibody discovery, today announced financial results for the third quarter of 2021. All financial...

ABCL : 7.81 (-6.69%)
How Much Upside is Left in AbCellera Biologics Inc. (ABCL)? Wall Street Analysts Think 161%

The consensus price target hints at a 160.5% upside potential for AbCellera Biologics Inc. (ABCL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings...

ABCL : 7.81 (-6.69%)
AbCellera Announces Virtual Presentations at Investor Conferences in November

AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the following virtual investor conferences:

ABCL : 7.81 (-6.69%)
Lilly to Supply 614,000 Additional Doses of AbCellera-Discovered Bamlanivimab Together with Etesevimab to the U.S. Government for the Treatment or Post-Exposure Prevention of COVID-19

AbCellera (Nasdaq: ABCL) today announced an additional purchase by the U.S. government from Eli Lilly and Company (Lilly) for bamlanivimab with etesevimab for administration together. This neutralizing...

ABCL : 7.81 (-6.69%)
AbCellera to Report Third Quarter 2021 Financial Results on November 9, 2021

AbCellera (Nasdaq: ABCL) will announce its third quarter 2021 financial results on Tuesday, November 9, 2021, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the...

ABCL : 7.81 (-6.69%)
AbCellera and Everest Medicines Announce Multi-Target Collaboration to Advance New Antibody Therapies

AbCellera (Nasdaq: ABCL) and Everest Medicines Limited (HKEX 1952.HK, “Everest”) announced today that they have entered into a multi-year collaboration and license agreement to discover therapeutic...

ABCL : 7.81 (-6.69%)

Barchart Exclusives

Crude Oil: $200 of Bust!
A long time ago, when the chatter surrounding crude oil was again overheated, the structure of the market was dramatically different. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar